Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
31.60
-0.96 (-2.95%)
At close: Mar 28, 2025, 4:00 PM
31.71
+0.11 (0.34%)
After-hours: Mar 28, 2025, 7:56 PM EDT
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $3.80 billion as of March 28, 2025. Its market cap has increased by 91.62% in one year.
Market Cap
3.80B
Enterprise Value
2.30B
1-Year Change
91.62%
Ranking
Category
Stock Price
$31.60
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $1.01B to $3.80B, an increase of 277.04%. That is a compound annual growth rate of 31.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 3.80B | 9.49% |
| Dec 31, 2024 | 3.47B | 417.36% |
| Dec 29, 2023 | 670.62M | -54.52% |
| Dec 30, 2022 | 1.47B | 32.27% |
| Dec 31, 2021 | 1.11B | 16.40% |
| Dec 31, 2020 | 957.68M | -4.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |